Qube Research & Technologies (QRT)
AHCO icon

Qube Research & Technologies (QRT)’s AdaptHealth AHCO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-72,690
Closed -$724K – 3493
2025
Q4 		$724K Buy
+72,690
New +$694K ﹤0.01% 2688
2024
Q1 		– Sell
-29,704
Closed -$217K – 4424
2023
Q4 		$217K Buy
+29,704
New +$234K ﹤0.01% 2748
2023
Q1 		– Sell
-19,055
Closed -$366K – 2495
2022
Q4 		$366K Sell
19,055
-22,589
-54% -$478K ﹤0.01% 1589
2022
Q3 		$782K Buy
+41,644
New +$856K ﹤0.01% 1287
2022
Q2 		– Sell
-54,386
Closed -$872K – 2442
2022
Q1 		$872K Buy
+54,386
New +$978K 0.01% 1238

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AHCO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 72,690 shares — an estimated $724K sold.

Qube Research & Technologies (QRT) first reported a position in AHCO in Q1 2022 and held it in 5 quarters. The position peaked at $872K in Q1 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 72,690 AdaptHealth shares in Q1 2026, an estimated $724K.
  • Qube Research & Technologies (QRT) first reported a position in AdaptHealth in Q1 2022 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s AdaptHealth position peaked at $872K in Q1 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.